Increased Emphasis on Downstream Processing Key Trend in Biopharmaceuticals Market
London, UK. The reduced efficacy of existing drugs and a lack of treatments for many new diseases are expected to drive expansion in the biopharmaceuticals market. To benefit from this opportunity, participants must focus on improving the competence of downstream processing, which has been a long-standing time-scale and technology bottleneck in an otherwise efficient manufacturing process.
Limited investment and lack of innovation in downstream processing accounts for 40 per cent of biopharmaceutical production expenses and result in costly delays.
New analysis from Frost & Sullivan (www.biotech.frost.com), World Strategic Analysis of Downstream Processing in Biopharmaceuticals Production, reveals that the contract manufacturing revenue in this market totalled USD 3.8 billion in 2004 and is projected to reach USD 9.2 billion in 2010.
Historically, there has been a lack of interest in downstream processing in comparison to upstream technologies. However, these issues are now being addressed through the development of innovative technologies by new investors and the existing multinationals.
"Trends include a move toward high-throughput membrane chromatography systems and the provision of integrated technology solutions," says Frost & Sullivan Research Analyst Phil Webster. "Participants are investing in increased volumetric throughput of apparatus and automated systems to increase production efficiency."The cost of installing or developing in-house downstream systems and staying abreast of technology developments is encouraging drug discovery firms to outsource different stages of manufacturing of their procedures. As a result, contract manufacturing organisations (CMOs) are gaining prominence.CMOs, in turn, are developing their own infrastructure to offer improved facilities for gaining a foothold in an increasingly competitive market. Due to this, investment in R&D is also expected to increase.
Another market driver is the growing competition for benchmark apparatus and consumables in the biopharmaceuticals market. This is compelling participants to develop original technologies to out-perform existing systems. Participants are also forming tactical alliances with other technology providers to provide end users with enhanced integrated solutions.
The Strategic Analysis of Downstream Processing in Biopharmaceuticals Production is a part of the Biotechnology subscription. The study offers a comprehensive overview of downstream processing technology dynamics and the worldwide CMO market. It also provides in-depth information on industry trends, revenue forecasts, market drivers, and challenges that is anticipated to help participants in effectively identifying and capitalising on growth opportunities. Analyst interviews are available to the press.
If you are interested in an analysis overview providing summary, challenges and latest trends in Downstream Processing in Biopharmaceuticals Production please use 'Contact / Info'-button.
Other news from the department business & finance
These products might interest you
SepsiTest™-UMD CE IVD by Molzym
Make yourself independent: 16S/18S PCR for pathogen identification
Fast and precise detection of bacteria and fungi in blood/body fluids and tissue
SureSTART Vials and Well Plates by Thermo Fisher Scientific
SureSTART autosampler vials for all chromatography applications and budgets
3 performance level: Easily select products suited to your analytical, performance or value needs
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
Starlab product guide by STARLAB
From pipette tips to centrifuges - laboratory equipment for every need
Discover the Starlab product range now!
Ksep® Consumable Kits by Sartorius
Ksep® Kits: Cell clarification and harvesting made easy
Automated solutions for higher yield and quality in bioprocessing
Sartobind® Rapid A by Sartorius
Efficient chromatography with disposable membranes
Increase productivity and reduce costs with fast cycle times
Consumables & Instruments by Azenta
Azenta's Sample Consumables and Instruments
Improve sample tracking, ensure sample integrity, and drive process efficiency
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
